Joint (NASDAQ:JYNT) Upgraded to Buy at StockNews.com

StockNews.com upgraded shares of Joint (NASDAQ:JYNT) from a hold rating to a buy rating in a research note released on Monday.

JYNT has been the topic of several other reports. TheStreet downgraded shares of Joint from a c- rating to a d rating in a report on Thursday, March 7th. B. Riley raised their price target on shares of Joint from $12.00 to $20.00 and gave the company a buy rating in a research note on Monday. Finally, Roth Mkm reiterated a buy rating and set a $16.00 price objective (up from $13.00) on shares of Joint in a research note on Friday. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of Moderate Buy and an average price target of $22.00.

Joint Price Performance

JYNT stock opened at $15.79 on Monday. Joint has a 52-week low of $7.31 and a 52-week high of $16.35. The company’s 50-day simple moving average is $12.17 and its 200-day simple moving average is $10.21.

Joint (NASDAQ:JYNT) last issued its quarterly earnings results on Thursday, March 7th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.04. The company had revenue of $30.61 million for the quarter, compared to the consensus estimate of $29.63 million. Joint had a positive return on equity of 3.94% and a negative net margin of 9.24%. On average, sell-side analysts forecast that Joint will post 0.13 EPS for the current year.

Institutional Trading of Joint

A number of hedge funds have recently bought and sold shares of JYNT. Skylands Capital LLC grew its position in shares of Joint by 20.3% in the fourth quarter. Skylands Capital LLC now owns 603,640 shares of the company’s stock valued at $5,801,000 after purchasing an additional 101,850 shares in the last quarter. First Foundation Advisors purchased a new position in shares of Joint during the 3rd quarter worth $1,336,000. Verus Capital Partners LLC grew its holdings in shares of Joint by 24.0% in the third quarter. Verus Capital Partners LLC now owns 108,370 shares of the company’s stock valued at $974,000 after purchasing an additional 20,950 shares during the period. O Brien Greene & Co. Inc grew its holdings in shares of Joint by 12.1% in the third quarter. O Brien Greene & Co. Inc now owns 102,020 shares of the company’s stock valued at $917,000 after purchasing an additional 11,000 shares during the period. Finally, Hudson Bay Capital Management LP purchased a new position in Joint during the third quarter worth about $867,000. Institutional investors and hedge funds own 76.88% of the company’s stock.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.